| IS | S2AI | p |
---|---|---|---|
No. of patients | 111 | 31 | Â |
Age, (yrs) | 67.9 ± 16.7 | 65.2 ± 15.8 | 0.422 |
Female sex, n (%) | 92 (82.8) | 25 (80.6) | 0.772 |
BMI, (kg/m2) | 28.5 ± 8.7 | 27.6 ± 8.2 | 0.607 |
Follow-up, (mos) | 32.8 ± 8.0 | 30.7 ± 6.2 | 0.179 |
Smoking, n (%) | 12 (10.8) | 5 (16.1) | 0.530 |
Diabetes, n (%) | 32 (28.8) | 9 (29.0) | 0.982 |
Osteoporosis, n (%) | 53 (47.7) | 13 (41.9) | 0.566 |
Hypertension, n (%) | 11 (9.9) | 5 (16.1) | 0.518 |
Primary diagnosis, n (%) | Â | Â | 0.891 |
 Degenerative | 72 (64.95) | 19 (61.3) |  |
 Idiopathic | 14 (12.6) | 4 (12.9) |  |
 Congenital | 7 (6.3) | 3 (9.7) |  |
 Post-traumatic | 18 (16.2) | 5 (16.1) |  |
ASA class, n (%) | Â | Â | 0.379 |
 I | 14 (12.6) | 7 (22.6) |  |
 II | 79 (71.2) | 19 (61.3) |  |
 III | 18 (16.2) | 5 (16.1) |  |
No. of levels fused | 8.82 ± 3.7 | 8.65 ± 7.6 | 0.084 |
UIV level, n (%) | Â | Â | 0.802 |
 Above T10 | 9 (8.1) | 2 (6.5) |  |
 T10 | 89 (80.2) | 24 (77.4) |  |
 Below T10 | 13 (11.7) | 5 (16.1) |  |
Interbody fusion level | |||
 L1/2 | 11 (9.9) | 2 (6.5) | 0.734 |
 L2/3 | 101 (90.9) | 27 (87.1) | 0.506 |
 L3/4 | 109 (98.2) | 29 (93.5) | 0.208 |
 L4/5 | 110 (99.1) | 30 (96.8) | 0.390 |
 L5/S1 | 109 (98.2) | 30 (96.8) | 0.525 |
PSO level, n (%) | |||
 L2 | 5 (4.5) | 2 (6.5) | 0.647 |
 L3 | 8 (7.2) | 3 (9.7) | 0.705 |
 L4 | 2 (1.8) | 1 (3.2) | 0.525 |
Surgical duration (mins) | 388.2 ± 99.1 | 377.6 ± 102.1 | 0.602 |
Blood loss (ml) | 2421.2 ± 255.1 | 2368.3 ± 354.1 | 0.353 |
Length of stay (days) | 20.6 ± 5.7 | 19.1 ± 6.8 | 0.217 |